AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹4,209 Cr | ₹3,743 Cr | ₹3,341 Cr | ₹2,890 Cr | ₹2,588 Cr |
What is the latest Revenue of AJANTA PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹4,209 Cr |
Mar2023 | ₹3,743 Cr |
Mar2022 | ₹3,341 Cr |
Mar2021 | ₹2,890 Cr |
Mar2020 | ₹2,588 Cr |
How is Revenue of AJANTA PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹4,209 Cr | 12.45 | |
Mar2023 | ₹3,743 Cr | 12.02 | |
Mar2022 | ₹3,341 Cr | 15.62 | |
Mar2021 | ₹2,890 Cr | 11.66 | |
Mar2020 | ₹2,588 Cr | - |
Compare Revenue of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹31,517.3 Cr | -9.5% | -10.4% | 20.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -9.5% |
-10.4% |
20.2% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses